Logo image
Large Vessel Occlusion Stroke due to Intracranial Atherosclerotic Disease: Identification, Medical and Interventional Treatment, and Outcomes
Journal article   Open access   Peer reviewed

Large Vessel Occlusion Stroke due to Intracranial Atherosclerotic Disease: Identification, Medical and Interventional Treatment, and Outcomes

Adam de Havenon, Osama O Zaidat, Sepideh Amin-Hanjani, Thanh N Nguyen, Aaron Bangad, Mehdi Abbasi, Mohammad Anadani, Eyad Almallouhi, Rano Chatterjee, Mikael Mazighi, …
Stroke (1970), Vol.54(6), pp.1695-1705
06/2023
DOI: 10.1161/STROKEAHA.122.040008
PMCID: PMC10202848
PMID: 36938708
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC10202848/pdf/nihms-1880520.pdfView
Open Access

Abstract

Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk factors, race and ethnicity, and age. Patients with ICAD-LVO derive similar functional outcome benefit from endovascular thrombectomy as other mechanisms of LVO, but up to half of ICAD-LVO patients reocclude after revascularization. Therefore, early identification and treatment planning for ICAD-LVO are important given the unique considerations before, during, and after endovascular thrombectomy. In this review of ICAD-LVO, we propose a multistep approach to ICAD-LVO identification, pretreatment and endovascular thrombectomy considerations, adjunctive medications, and medical management. There have been no large-scale randomized controlled trials dedicated to studying ICAD-LVO, therefore this review focuses on observational studies.
Stroke risk factors intracranial atherosclerosis thrombectomy mortality

Details

Logo image